Lerapolturev

莱锐妥若

Report date: 2022/07/04 19:38:02

Base Information

Drug NameLerapolturev
Drug Alias NameSabin type 1 polio vaccine - Istari OncologyPVSRIPOPVS-RIPOPolio Virus Sabin-Rhinovirus PoliovirusRe-engineered poliovirus
ClassificationVaccines > Application > Therapeutic vaccineVaccines > Biological material > Viral vaccineVaccines > Development/production technology > Recombinant vector vaccine +[4] 
Mechanisms of ActionImmunostimulantsPoliovirus receptor modulators
TargetsPoliovirus receptor
Therapy Area/IndicationsSolid tumoursUrinary Bladder NeoplasmsBrain Neoplasms +[13] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesIstari Oncology IncDuke University Medical CenterNational Cancer Institute
China Registration ClassN/A

Develop Information

Active CompaniesIstari Oncology IncNational Cancer Institute
Inactive CompaniesN/A
Active IndicationsBrain NeoplasmsBreast NeoplasmsMelanoma +[11] 
Inactive IndicationsSolid tumoursUrinary Bladder Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A